Podiatrists in Michigan City, IN Accepting Medicare

9 Podiatrists found. Showing 1 - 9

Hardeep S Minhas, D.P.M. Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 8733 W 400 N, Michigan City, IN 46360 Phone: 219-315-4458    Fax: 866-343-0937

Lakeshore Bone & Joint Institute, Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 1550 S Woodland Ave, Michigan City, IN 46360 Phone: 219-921-1444    Fax: 219-921-5303

Joseph George Wilson Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 10176 W 400 N Ste D, Michigan City, IN 46360 Phone: 219-214-2047

Momentum Foot And Ankle Clinics Podiatrist - Foot & Ankle Surgery Medicare: Medicare Enrolled Practice Location: 10176 W 400 N Ste D, Michigan City, IN 46360 Phone: 219-214-2047

The Foot And Ankle Clinics Pc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 10176 W 400 N Ste B, Michigan City, IN 46360 Phone: 219-809-9839    Fax: 219-809-9841

Dr. Thomas V. Tsoutsouris Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 1403 Franklin St, Michigan City, IN 46360 Phone: 219-874-8515

Dr. Aamir Mahmood, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 10176 W 400 N Ste D, Michigan City, IN 46360 Phone: 219-214-2047

Nwi Foot And Ankle Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 8733 W 400 N, Michigan City, IN 46360 Phone: 219-315-4458    Fax: 866-343-0937

Advanced Foot & Ankle Center Llc Podiatrist - Foot & Ankle Surgery Medicare: Not Enrolled in Medicare Practice Location: 111 Boyd Cir, Michigan City, IN 46360 Phone: 219-405-3775    Fax: 219-405-3775

News Archive

New Hill-Rom's Advanta 2 Bed for hospitals and home care facilities

Hill-Rom today announced the introduction of Hill-Rom's Advanta(TM) 2 Bed for use in medical-surgical areas of hospitals and care facilities. The new bed brings together ease of use with key safety features and the flexibility to use a variety of care surfaces as needed.

Sanofi presents positive phase 3 data for GLP-1 receptor for type 2 diabetes

Sanofi US (EURONEXT: SAN and NYSE: SNY) announced today data that showed lixisenatide, an investigational once-daily prandial glucagon-like peptide 1 (GLP-1) receptor agonist, decreased HbA1c by reducing PPG (postprandial glucose) daytime exposure when added to standard of care which includes basal insulin with or without oral anti-diabetic agents (OADs). Lixisenatide is for the treatment of adults with type 2 diabetes mellitus.

ACTU says 1.5 million workers are exposed to cancer-causing chemicals

According to the Australian Council of Trade Unions (ACTU), exposure to cancer-causing substances at work threatens the health and well being of as many as 1.5 million Australians.

Human immune system in a test tube

Surgical instruments or implants that are contaminated with residual bacteria, or pyrogens, can cause blood poisoning in patients. Researchers are developing a test that imitates the human immune system in the laboratory, eliminating the need for animal experiments.

Read more Medical News

› Verified 6 days ago